References
- Welin L., Eriksson H., Ohlson L. O., Svärdsudd K., Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men. Diabetologia 1992; 35: 766–770
- Heaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
- Ferrannini E. Metabolic abnormalities of hypertension. A lesson in complexity. Hypertension 1991; 18: 636–639
- Black H. R. The coronary artery disease paradox: the role for hyperinsulinemia and insulin-resistance, implications for therapy. J. Cardiovasc. Pharmacol. 1990; 15(suppl. 5)S26–S38
- Modan M., Halkin H., Almog S., et al. Hyperinsulinemia, a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 1985; 75: 809–817
- Singer P., Godicke W., Voigt S., Hadju I., Weiss M. Postprandial hyperinsulinemia in patients with mild hypertension. Hypertension 1985; 7: 182–186
- Manicardi V., Camellini L., Bellodi G., Coscelli C., Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J. Clin. Endocrinol. Metab. 1986; 62: 1302–1304
- Ferrannini E., Buzzigoli G., Bonadonna R., et al. Insulin resistance in essential hypertension. N. Engl. J. Med. 1987; 317: 350–357
- Reisin E., Abel R., Modan M., Silverberg D. S., Eliahou H. E., Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 1978; 298: 1–6
- Krotiewski M., Mandroukas K., Sjöström L., Sullivan L., Wetterqvist H., Björntorp P. Effects of long-term physical training on body fat, metabolism and blood pressure in obesity. Metabolism 1979; 28: 650–658
- Haffner S. M., Stern M. P., Hazuda H. P., Mitchell B. D., Patterson J. K., Ferrannini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 1989; 9: 928–933
- Allemann Y., Horber F. F., Colombo M., et al. Insulin sensitivity and body fat distribution in normotensive offsprings of hypertensive parents. Lancet 1993; 341: 327–331
- Saad M. F., Lillioja S., Nyomba B. L., et al. Racial differences in the relation between blood pressure and insulin resistance. N. Engl. J. Med. 1991; 38: 784–792
- Chaiken R. L., Banerji M. A., Huey H., Lebovitz H. E. Do blacks with NIDDM have an insulin resistance syndrome?. Diabetes 1993; 42: 444–449
- De Fronzo R. A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194
- Kannel W. B. Status of risk factors and their consideration in antihypertensive therapy. Am. J. Cardiol. 1987; 59: 80–90
- Ames R. P. Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies. Am. J. Cardiol. 1983; 51: 632–638
- Weinberger M. H. Antihypertensive therapy and lipids: evidence, mechanisms and implications. Arch. Intern. Med. 1985; 145: 1102–1105
- Swislocki A. L.M., Hoffman B. B., Reaven G. M. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am. J. Hypertens. 1989; 2: 419–423
- Skarfors E. T., Lithell H. O., Selinus I., Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men?. Br. Med. J. 1989; 298: 1147–1152
- Pollare T., Lithell H., Berne C. - A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N. Engl. J. Med. 1989; 321: 868–873
- Pollare T., Lithell H., Selinus I., Berne C. - Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988; 31: 415–420
- Pollare T., Lithell H., Morlin C., Prantare H., Huarfner A., Ljunghall S. - Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J. Hypertens. 1989; 7: 551–559
- Pollare T., Lithell H., Selinus I., Berne C. - Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized double-blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br. Med. J. 1989; 298: 1152–1157
- Rodnick K. J., Haskell W. L., Swislocki A. L.M., Foley J. E., Reaven G. M. Improved insulin action in muscle, liver and adipose tissue in physically trained human subjects. Am. J. Physiol. 1987; 253: 489–495
- Menard J., Cornu P., Day M. Cost of hypertension treatment and the price of health. J. Hum. Hypertens. 1992; 6: 447–458